PCOS Affects 5 Million US Women, Yet No Drug Has Ever Been Approved for It

On average, women with PCOS wait years for a diagnosis, some see three or more doctors before getting an answer. Here's what's really going on with this common hormone disorder, and why research into it looks so different from most other conditions.

Author image

Written by Valerii Vasilevskyi, MD, PhD

Published 1 September 2026

Here is a fact that surprises most people, including many who have lived with PCOS for years. Not a single drug on the market carries an FDA approval for polycystic ovary syndrome. Not one. A condition that affects as many as 5 million women in the US, and about 1 in 10 women of reproductive age worldwide, is treated entirely with medicines borrowed from other diseases.

That does not mean nothing works. Doctors have real tools, and they use them every day. But it explains a lot about the PCOS experience, all the trial and error and the feeling that treatment is a patchwork. It also explains why clinical trials matter more in PCOS than in almost any other common condition. This article walks through what doctors prescribe now, what researchers are testing, and why progress has been slow.

Looking for treatment options for PCOS?

Browse open PCOS clinical trials near you! We'll handle the follow-up.

What doctors prescribe today

Every medicine below is used off label in PCOS. Each was approved for something else, and doctors apply it to the part of PCOS it happens to help.

Metformin. A diabetes medicine. Many women with PCOS have insulin resistance, meaning the body makes insulin but cannot use it well, and the extra insulin pushes the ovaries to make even more androgens. Metformin helps the body respond to its own insulin, which takes pressure off that loop. Researchers are still probing what else this borrowed drug can do: a University of Alberta trial recruiting now pairs metformin with fish oil to study heart health in 146 women with PCOS.

Combined birth control pills. Approved for contraception and for acne. In PCOS, doctors use them to make cycles predictable and to calm the effects of excess androgens, like acne and unwanted hair growth.

Spironolactone. A medicine approved for other conditions that happens to block androgens from acting on the skin and hair. Doctors add it when acne or hair growth is the main concern.

Letrozole. Approved as a breast cancer drug. In PCOS it is used for something completely different: nudging the ovaries to ovulate, which helps women who are trying to conceive.

Clomiphene. Approved for ovulation problems in general, not for PCOS specifically. Doctors use it to trigger ovulation.

Notice the pattern. Insulin, cycles, skin, ovulation. Each drug patches one symptom. None of them was designed for PCOS as a whole, because no such drug exists yet.

What researchers are studying now

This is where it gets hopeful. As of August 2026, 97 PCOS studies are recruiting worldwide, and a few new approaches look nothing like the usual playbook.

A one-time ovarian procedure. A company called May Health is developing a one-time procedure for PCOS-related infertility. In early studies, about 4 in 10 women started ovulating on their own within three months, and even more did once fertility medicines were added back in. The FDA has authorized the company's US trial, and in March 2026 the company raised $11.7 million to keep it moving. A single procedure instead of ongoing medication would be a real shift for PCOS care.

A malaria drug, of all things. In 2024, researchers found that artemisinins, the drug family used for malaria, can lower androgen levels in the ovaries. In a small pilot, 19 women with PCOS took a related pill for 12 weeks. Most saw their androgen levels drop, and more than half got more regular cycles. It's very early, and a small pilot doesn't prove much on its own, but it's one of the first attempts to treat the actual source of the problem.

Head-to-head academic studies. Universities are quietly answering practical questions pharma never asked. A University of Pennsylvania trial compared birth control pills, metformin, and the two combined for PCOS-related metabolic issues, with results out in December 2025. The University of Illinois Chicago tested an anti-inflammatory drug called salsalate the same year. Researchers are also looking into GLP-1 drugs, inositol supplements, and various devices.

One more thing worth knowing: many of the studies recruiting right now aren't testing a drug at all. They look at lifestyle, supplements, devices, or how the body works. One example: a McGill University study is testing a ketone supplement in 60 women with PCOS. And most of the top sponsors are universities, like the University of Virginia, UCSF, and Oulu University Hospital in Finland, not drug companies.

Why PCOS research takes so long

If PCOS is so common, why is there still no approved drug? Three problems come up again and again.

The measurement problem. PCOS isn't one uniform disease. Diagnosis rests on three features, irregular ovulation, excess androgens, and polycystic-appearing ovaries, and different women have different combinations. So there's no single agreed way to measure success. Fertility trials count ovulation and pregnancies. Hormone trials measure testosterone and hair growth. Metabolic trials measure insulin resistance. It's hard for a drug company to run one big trial when the field can't agree on what "better" even means.

The industry problem. Look at who runs PCOS studies and you won't find big pharma among the lead sponsors. The field runs on university and hospital budgets, which means smaller studies, slower timelines, and no one pushing a single therapy through the full approval process. Zero PCOS-specific drug approvals is the direct result.

The representation problem. You can't join a trial for a condition nobody diagnosed you with. A 2025 study found that women in socially vulnerable groups are less likely to be diagnosed with PCOS at all. Teenagers are understudied even though symptoms usually start around the first period. And many trials set weight cutoffs that exclude lean women with PCOS entirely. So research risks describing only a slice of the people who actually have the condition. Some studies are working on exactly this: a 150-person study is looking at how insulin sensitivity differs by age, sex, race, ethnicity, and weight in people with and without PCOS.

PCOS affects more than the ovaries

The name points at the ovaries, but PCOS is just as much a metabolic condition. According to the CDC, more than half of women with PCOS develop type 2 diabetes by age 40. It's also linked to heart disease, high blood pressure, unhealthy cholesterol, sleep apnea, stroke, depression, and anxiety, along with a higher risk of endometrial cancer.

What is PCOS belly?

Belly fat deserves its own mention. The WHO lists weight gain, especially around the belly, as a common PCOS symptom, and insulin is behind it. When the body can't use insulin well, insulin levels stay high. High insulin promotes fat storage around the middle and pushes androgen levels up, and androgens shift where fat goes, toward the belly instead of the hips or thighs. That belly fat then makes insulin resistance worse, so the cycle feeds itself. This pattern is what many women call PCOS belly, and it's one more reason researchers treat PCOS as a whole-body condition, not just an ovarian one.

Researchers are also studying the long term picture seriously. A Finnish study found that women with PCOS were about 1.5 times as likely to die during the study period as women the same age without it, and a 2026 study reported increased mortality too. This whole-body view has reached recruitment: a Cleveland Clinic study enrolling now tracks quality of life and metabolic outcomes together in women with PCOS. These are population-level patterns, not predictions about any one person. If you have PCOS, the takeaway is simple: treat it as a whole-body condition, and talk with your doctor about your metabolic health, not just your cycle.

Common myths about PCOS

"You cannot get pregnant if you have PCOS."

Not true. PCOS makes ovulation irregular, and it is a common cause of infertility, but many women with PCOS conceive, some on their own and some with medical help. Restoring ovulation is one of the most active goals in current trials.

"PCOS is only a fertility problem."

The diabetes, heart, and mental health links above say otherwise. Women who are not planning a pregnancy still benefit from taking PCOS seriously.

"Only overweight women get PCOS."

Lean women get PCOS too. In fact, researchers point out that BMI cutoffs in many trials exclude lean PCOS patients, which is part of the representation problem, not proof that they do not exist.

Does PCOS have stages?

No. Unlike many conditions, PCOS has no staging system, no grade 1 to 4. The closest thing is the phenotype system (A through D) describing which of the three diagnostic features a woman has. In practice, what matters for treatment and for trials is not a stage but a focus: is the main concern fertility, metabolism, or androgen symptoms like acne and hair growth? Studies usually recruit along those same lines, so knowing which part of PCOS affects you most is the fastest way to spot studies that fit.

Common questions

What is PCOS, in simple terms? PCOS, short for polycystic ovary syndrome, is a hormonal condition driven by higher than normal androgen levels from the ovaries. Insulin resistance usually comes along with it, and that combination disrupts ovulation, which is why periods turn irregular and pregnancy can take longer. Signs often show up in the teenage years, though plenty of women only get answers much later.

Is any drug FDA approved specifically for PCOS? No. Everything used today, including metformin, birth control pills, spironolactone, letrozole, and clomiphene, was approved for other conditions and is prescribed off label in PCOS. Trials now recruiting are working toward the first PCOS-specific treatments.

Is PCOS genetic? Genes matter a lot. In a large Dutch twin study, genetics explained about 70 percent of PCOS risk. Your risk is also higher if your mother, sister, or aunt has PCOS.

Is PCOS an autoimmune disease? No. Doctors classify PCOS as a hormonal and metabolic condition, not an autoimmune disease.

What causes PCOS? Doctors do not know the exact cause of PCOS. Part of the answer is genetic, since PCOS runs in families. Hormones and insulin also interact, and that mix throws off ovulation. Researchers are still trying to work out the full picture.

How do doctors test for PCOS? There is no single test. Doctors look at irregular or missing periods, signs of excess androgens such as extra hair growth or acne, and the appearance of the ovaries. It can take time: in one large international survey, about 1 in 3 women waited more than two years for their diagnosis. Many never find out at all: by WHO estimates, up to 7 in 10 affected women remain undiagnosed.

Can you get pregnant with PCOS? Yes, many women with PCOS get pregnant. PCOS disrupts ovulation, and the CDC calls it a common cause of infertility in women, so it may take longer or need medical help. Fertility is also one of the areas PCOS clinical trials study most.

See PCOS clinical trials recruiting near you:

PCOS Clinical Trials

Share this article on social media: